Navigation Links
Morningstar Healthcare Analysts to Discuss Top 15 Biotech Acquisition Targets on Wednesday, March 4 at 11 a.m. EST
Date:2/27/2009

CHICAGO, Feb. 27 /PRNewswire-FirstCall/ -- Morningstar, Inc. (Nasdaq: MORN), a leading provider of independent investment research, is holding a conference call for institutional investors including portfolio managers at mutual funds, hedge funds, pensions, and endowments. The topic of the call is "The Top 15 Biotech Acquisition Targets" and it will be held at 11 a.m. EST, 10 a.m. CST on Wednesday, March 4.

Damien Conover, CFA, Morningstar's equity strategist for the healthcare sector and the Morningstar Healthcare Observer institutional newsletter, will share the results of analysis conducted by Morningstar's team of 12 healthcare analysts on the 63 biotech companies they cover. The team ranked each company by its likelihood of being acquired based upon a methodology that weighed drug portfolio strength, profit-boosting power, collaborative fit, financial health, and recent stock performance.

Conover will be joined on the call by biotech analyst Karen Andersen.

Institutional investors: To obtain dial-in instructions, please RSVP with your name and company name to Heather Brilliant, Morningstar's Director of Stock Analysis, at hbrilliant@morningstar.com.

Press registration: To obtain dial-in instructions, please RSVP to Courtney Goethals Dobrow at courtney.dobrow@morningstar.com.

About Morningstar, Inc.

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offers an extensive line of Internet, software, and print-based products and services for individuals, financial advisors, and institutions. Morningstar provides data on more than 300,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time pricing data on more than 4 million global equities, commodities, derivatives, indexes, and foreign currencies. The company has operations in 19 countries and minority ownership positions in companies based in three other countries.

    (C)2009 Morningstar Inc.  All rights reserved.

     Media Contact:
     Courtney Goethals Dobrow 312-696-6241, courtney.dobrow@morningstar.com

'/>"/>
SOURCE Morningstar, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Abbott to Present at Barclays Global Healthcare Conference
2. Healthcare Executives Will Discuss How Best to Spend Economic Stimulus Money at June Conference
3. Jennifer Brownstein, of CONNEXION Healthcare, Honored as Rising Star by Healthcare Businesswomens Association
4. LAB research to present at upcoming UBS 2009 global healthcare services conference in New York
5. BMP Sunstone to Present at UBS Global Healthcare Services Conference
6. Genesis HealthCare Promotes Wendy LaBate To Senior Vice President of Operations for the Northeast Area
7. IPC The Hospitalist Company, Inc. to Present at UBS 2009 Global Healthcare Services Conference
8. AMDL First to Implement US & China-Based, GAAP-Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market
9. bioMerieux Introduces Surveillance Tool to Fight Healthcare-Associated Infections
10. Malaysian Healthcare Industry Is in Good Shape
11. Keryx Biopharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 2017 In today,s pre-market research, ... the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate ... SYN), and Regulus Therapeutics Inc. (NASDAQ: RGLS ... Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn ... at: ...
(Date:3/22/2017)... 22, 2017  Ascendis Pharma A/S (Nasdaq: ASND), ... technology to address significant unmet medical needs in ... full year ended December 31, 2016. ... company as we broadened our pipeline and pursued ... disease company with an initial focus on endocrinology," ...
(Date:3/22/2017)... --  iSpecimen ®, the marketplace for human ... (DPS), a full-service anatomic pathology reference lab serving ... , has joined a program offered by iSpecimen ... to make human biospecimens and associated data available to ... in 2015 as a collaboration between iSpecimen and DHIN, ...
(Date:3/22/2017)... Mass. , March 22, 2017   Boston ... next-generation cancer therapeutics designed to target cancer stemness pathways, ... Patricia S. Andrews as Chief Executive Officer, effective ... succeed Chiang J. Li , M.D., FACP, who ... ten years ago. Under his leadership, Boston Biomedical has ...
Breaking Biology Technology:
(Date:3/1/2017)... 2017  Aware, Inc. (NASDAQ: AWRE), a leading supplier ... P. Moberg has resigned, effective March 3, 2017, ... Officer and Treasurer of Aware citing a desire to ... member of the Board of Directors of Aware. ... Officer and co-President, General Counsel has been named Chief ...
(Date:2/27/2017)... 2017   Strategic Cyber Ventures , the industry,s ... a $3.5 million investment in  Polarity , the first ... is DC based and is led by cybersecurity veterans ... Ron Gula , also a longtime cybersecurity veteran ... this series A round of funding. This new funding ...
(Date:2/21/2017)... PORTLAND, Ore. , Feb. 22, 2017 /PRNewswire/ ... of Companies (Avamere Health Services, Infinity Rehab, Signature Hospice, ... study that will apply the power of IBM cognitive ... and health centers. By analyzing data streaming from sensors ... into physical and environmental conditions, and obtain deeper learnings ...
Breaking Biology News(10 mins):